Assets in USD of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Can-Fite BioPharma Ltd. quarterly Assets history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Assets for the quarter ending 30 Jun 2025 was $7.72M, a 30.4% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $7.72M +$1.8M +30.4% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $9.12M -$869K -8.7% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $5.92M -$5.11M -46.3% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $9.99M +$706K +7.61% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 $11M -$3.71M -25.2% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 $9.28M -$11M -54.2% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 $14.7M +$5.07M +52.3% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 $20.3M +$10.7M +113% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 $9.68M -$3.12M -24.4% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 $9.52M +$1.35M +16.5% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 $12.8M -$867K -6.34% 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 $8.17M +$222K +2.79% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 $7.95M +$338K +4.44% 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.